Zeltiq Gets Approved in Europe for Non-Invasive Fat Reduction
UltraShape, there is a selective damage to fat cells; nerves and blood vessels were preserved. But “freeze-thaw necrosis” – the process of Zeltiq, can’t distinguish between the unwanted fat and normal tissue. Zeltiq takes months to show a result and can cause swelling after the treatment.
Finally, there have been several publications in Ultrashape in key journals along with dozens of abstracts reported at meetings. With over 150,000 Ultrashape treatments, Zeltiq has a big uphill battle!